Richard Cosgrove

GIPR agonism mediates weight-independent insulin sensitization by tirzepatide in obese mice

Ricardo J. Samms, Michael E. Christe, Kyla Collins et al. · Journal of Clinical Investigation · 2021 · 204 citations · Full text

GIP Receptor Agonism Attenuates GLP-1 Receptor Agonist–Induced Nausea and Emesis in Preclinical Models

Tito Borner, Caroline E. Geisler, Samantha M. Fortin et al. · Diabetes · 2021 · 163 citations · Full text

Food Intake, Glucose Tolerance, Insulin Signaling +17

GIPR Agonism Inhibits PYY-Induced Nausea-Like Behavior

Ricardo J. Samms, Richard Cosgrove, Brandy M. Snider et al. · Diabetes · 2022 · 59 citations · Full text

Pharmacotherapy, Experimental Pharmacology, Social Sciences +16

Risk-assessment and pharmacological prophylaxis of venous thromboembolism in hospitalized patients with chronic liver disease

Hanin A. Bogari, Asad E. Patanwala, Richard Cosgrove et al. · Thrombosis Research · 2014 · 52 citations

Pulmonary Embolism, Thrombosis, Venous Disease +13

The anti-obesity effect of FGF19 does not require UCP1-dependent thermogenesis

Patrick J. Antonellis, Brian A. Droz, Richard Cosgrove et al. · Molecular Metabolism · 2019 · 33 citations · Full text